Cyanotech Files Patent Application

October 1, 2000

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


Cyanotech Files Patent Application

KAILUA-KONA, Hawaii--Cyanotech filed a U.S. patent application for its brand of astaxanthin, BioAstin, and its effects on muscle soreness and recovery time. In a preliminary study, Cyanotech found that volunteers taking 2 to 4 mg per day for five to seven days prior to strenuous exercise reported significantly reduced muscle soreness.

This is the fourth U.S. patent application filed by Cyanotech for the protective properties associated withastaxanthin. For more information, visit www.cyanotech.com or Booth #1673 at SupplySide West.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like